Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q1 2020 Earnings

6FebConfirmed

Q2 2019

Q3 2019

Q4 2019

Q1 2020

-11

-9.59

-8.19

-6.78

Details

Expected EPS

-9.760337999999999

Actual EPS

-11.0017845

Surprise EPS

-1.24

Surprise Percent

+12.72%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -11.0017845 per share for Q1 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.